Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,041 public trials 1,178 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Sequential Therapy in Metastatic Renal Cell Carinoma

NCT01731158

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Charité Berlin Berlin, Germany

University Hospital Bonn Bonn, Germany

University Hospital Dresden Dresden, Germany

University Hospital Düsseldorf Düsseldorf, Germany

View all 13 locations

View Trial Details

Completed

Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients

NCT01446666

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)

NCT00946153

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Kashiwa-shi, Chiba, Japan

Kurume-shi, Fukuoka, Japan

Sapporo, Hokkaido, Japan

Kawasaki-shi, Kanagawa, Japan

View Trial Details

Completed

Sunitinib in Refractory Adrenocortical Carcinoma

NCT00453895

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Charite Berlin Berlin, Germany

Dept. of Medicine I, University of Wuerzburg Würzburg, Germany

View Trial Details

Completed

A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

NCT02053376

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +13 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)

NCT01925586

Conditions: Adenocarcinoma, Atypical Ductal Hyperplasia (ADH) of the Breast, Breast Carcinoma In Situ, +7 more
Locations: Yale University & Smilow Breast Center at Yale New Haven Hospital New Haven, Connecticut, United States

View Trial Details

Completed

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

NCT00688623

Conditions: Adenocarcinoma, Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoid Tumor, +13 more
Locations: Novartis Investigative Site Bordeaux, France

Novartis Investigative Site Lyon, France

Novartis Investigative Site Marseille, France

Novartis Investigative Site Paris, France

View all 40 locations

View Trial Details

Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

NCT01010126

Conditions: Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Tower Cancer Research Foundation Beverly Hills, California, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles County-USC Medical Center Los Angeles, California, United States

View all 61 locations

View Trial Details

Completed

Sorafenib and TRC105 in Hepatocellular Cancer

NCT01306058

Conditions: Adenocarcinoma, Adenoma, Adenoma, Liver Cell, +13 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma

NCT02191878

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Arizona Clinical Research Center Tucson, Arizona, United States

University of California San Francisco San Francisco, California, United States

Kansas City Research Institute Kansas City, Missouri, United States

Memorial Sloan Kettering Cancer Center New York, United States

View all 15 locations

View Trial Details